Virotherapy: A virus to find and destroy cancer cells without harming healthy cells
About this audiobook
What Is Virotherapy
Reprogramming viruses in order to cure illness is an example of virotherapy, which is a kind of treatment that makes use of biotechnology to turn viruses into therapeutic agents. Anti-cancer oncolytic viruses, viral vectors for gene therapy, and viral immunotherapy are the three primary subspecialties that fall under the umbrella term "virotherapy." Gene overexpression, gene knockout, and suicide gene delivery are the three distinct approaches that are used by these branches throughout the therapeutic process. Gene overexpression results in the addition of genetic sequences that make up for insufficient or nonexistent amounts of essential gene expression. Gene silencing or expression reduction may be achieved by gene deletion by using RNA-based techniques. The delivery of suicide genes involves the introduction of genetic sequences that trigger an apoptotic response in cells; this is often done in order to eliminate malignant growths. In a somewhat different setting, the term "virotherapy" may also refer to the use of viruses to cure certain medical problems by eliminating infections. This is one definition of the term.
How You Will Benefit
(I) Insights, and validations about the following topics:
Chapter 1: Virotherapy
Chapter 2: Gene therapy
Chapter 3: Immunotherapy
Chapter 4: Cancer vaccine
Chapter 5: Chimeric antigen receptor T cell
Chapter 6: Cancer immunotherapy
Chapter 7: Oncolytic virus
Chapter 8: Viral vector
Chapter 9: Murine respirovirus
Chapter 10: Oncolytics Biotech
Chapter 11: Pelareorep
Chapter 12: Molecular oncology
Chapter 13: Pexastimogene devacirepvec
Chapter 14: Talimogene laherparepvec
Chapter 15: Oncolytic herpes virus
Chapter 16: Oncolytic adenovirus
Chapter 17: Measles virus encoding the human thyroidal sodium iodide symporter
Chapter 18: Timeline of cancer treatment development
Chapter 19: Julianna Lisziewicz
Chapter 20: Oncolytic AAV
Chapter 21: Viral vector vaccine
(II) Answering the public top questions about virotherapy.
(III) Real world examples for the usage of virotherapy in many fields.
(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of virotherapy' technologies.
Who This Book Is For
Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of virotherapy.
About the author
Fouad Sabry is the former Regional Head of Business Development for Applications at HP in Southern Europe, Middle East, and Africa (SEMEA). Fouad has received his B.Sc. of Computer Systems and Automatic Control in 1996, dual masterâs degrees from University of Melbourne (UoM) in Australia, Master of Business Administration (MBA) in 2008, and Master of Management in Information Technology (MMIT) in 2010.
Fouad has more than 20 years of experience in Information Technology and Telecommunications fields, working in local, regional, and international companies, such as Vodafone and IBM in Middle East and Africa (MEA) region. Fouad joined HP Middle East (ME), based in Dubai, United Arab Emirates (UAE) in 2013 and helped develop the software business in tens of markets across Southern Europe, Middle East, and Africa (SEMEA) regions. Currently, Fouad is an entrepreneur, author, futurist, focused on Emerging Technologies, and Industry Solutions, and founder of One Billion Knowledgeable (1BK) Initiative.
